Availability, pricing and affordability of essential medicines in Eastern Ethiopia: a comprehensive analysis using WHO/HAI methodology

References

• Castillo CHM, Garrafa V, Cunha T, Hellmann F. El acceso a la salud como derecho humano en políticas internacionales: reflexiones críticas y desafíos contemporáneos. Cien Saude Colet. 2017;22:2151–2160.
   PubMedGoogle Scholar
• WHO. Health in 2015: from MDGs to SDGs. 2015.
   Google Scholar
• Bigdeli M, Laing R, Tomson G, Babar Z-U-D. Medicines and universal health coverage: challenges and opportunities. J Pharm Policy Pract. 2015;8(1):8.
   PubMedGoogle Scholar
• Wirtz VJ, Hogerzeil HV, Gray AL, Bigdeli M, de Joncheere CP, Ewen MA, et al. Essential medicines for universal health coverage. Lancet (London, England). 2017;389(10067):403–476
   PubMedGoogle Scholar
• Ozawa S, Shankar R, Leopold C, Orubu S. Access to medicines through health systems in low- and middle-income countries. Health Policy Plan. 2019;34(Supplement_3):iii1–iii3.
   PubMedGoogle Scholar
• WHO. Access to medicines: making market forces serve the poor 2017.
   Google Scholar
• Ahmadiani S, Nikfar S. Challenges of access to medicine and the responsibility of pharmaceutical companies: a legal perspective. DARU J Faculty Pharm Sci. 2016;24(1):13.
   PubMedGoogle Scholar
• Perehudoff SK, Alexandrov NV, Hogerzeil HV. Legislating for universal access to medicines: a rights-based cross-national comparison of UHC laws in 16 countries. Health Policy Plan. 2019;34(Supplement_3):iii48–iii57.
   PubMedGoogle Scholar
• WHO. Essential medicines. 2015.
   Google Scholar
• Kar SS, Pradhan HS, Mohanta GP. Concept of essential medicines and rational use in public health. Indian J Commun Med. 2010;35(1):10–13
   PubMedGoogle Scholar
• Peters DH, Garg A, Bloom G, Walker DG, Brieger WR, Rahman MH. Poverty and access to health care in developing countries. Ann N Y Acad Sci. 2008;1136:161–171.
   PubMed Web of Science ®Google Scholar
• Alsairi R. Access to medicine in developing countries. Am J Med Sci. 2017;7(6):271–276
   Google Scholar
• Gronde TV, Uyl-de Groot CA, Pieters T. Addressing the challenge of high-priced prescription drugs in the era of precision medicine: a systematic review of drug life cycles, therapeutic drug markets and regulatory frameworks. PLoS ONE. 2017;12(8): e0182613.
   PubMed Web of Science ®Google Scholar
• Cameron AHS, Whyte P, Ramsey S, Hedman L. WHO guideline on country pharmaceutical pricing policies. WHO. 2015.
   Google Scholar
• Zarif-Yeganeh M, Kargar M, Rashidian A, JafarzadehKohneloo A, Gholami K. Out of pocket payment and affordability of medication for geriatric patients in Tehran, Iran. Iran J Public Health. 2019;48(6):1124–1132.
   PubMed Web of Science ®Google Scholar
• WHO/HAI. Measuring medicine prices, availability, affordability and price components. 2nd ed. Geneva, Switzerland 2008.
   Google Scholar
• WHO/HAI. Measuring medicine prices, availability, affordability and price components World Health Organization & Health Action International. 2nd edn. 2016. 123–289.
   Google Scholar
• Raju PKS. Chapter 6.2—WHO/HAI methodology for measuring medicine prices, availability and affordability, and price components. In: Vogler S, editor. Medicine price surveys, analyses and comparisons. Academic Press: Cambridge; 2019. p. 209–228.
   Google Scholar
• Carasso BS, Lagarde M, Tesfaye A, Palmer N. Availability of essential medicines in Ethiopia: an efficiency-equity trade-off? Trop Med Int Health. 2009;14(11):1394–1400.
   PubMed Web of Science ®Google Scholar
• FMHACA. List of essential medicines for Ethiopia. Food, medicine and healthcare administration and control authority of Ethiopia. 4th edn. Addis Ababa. 2010.
   Google Scholar
• Wirtz VJ, Hogerzeil HV, Gray AL, Bigdeli M, de Joncheere CP, Ewen MA, et al. Essential medicines for universal health coverage. Lancet. 2017;389(10067):403–476.
   PubMedGoogle Scholar
• WHO. World Health Organization model list of essential medicines: 21st list 2019. World Health Organization, 2019.
   Google Scholar
• Atif M, Malik I, Dawoud D, Gilani A, Ahmed N, Babar Z-U-D. Essential medicine list, policies, and the world health organization. In: Babar ZUD, editor. Encyclopedia of pharmacy practice and clinical pharmacy. Elsevier: Oxford; 2019. p. 239–249
   Google Scholar
• WHO. The selection and use of essential medicines: report of the WHO Expert Committee, 2017 (including the 20th WHO model list of essential medicines and the 6th model list of essential medicines for children): World Health Organization; 2017.
   Google Scholar
• MoH/EFDA. Ethiopian Essential Medicines List. 2020.
   Google Scholar
• Mahmić-Kaknjo M, Jeličić-Kadić A, Utrobičić A, Chan K, Bero L, Marušić A. Essential medicines availability is still suboptimal in many countries: a scoping review. J Clin Epidemiol. 2018;98:41–52.
   PubMed Web of Science ®Google Scholar
• Bissell K, Perrin C, Beran D. Access to essential medicines to treat chronic respiratory disease in low-income countries. Int J Tuberc Lung Dis. 2016;20(6):717–728.
   PubMed Web of Science ®Google Scholar
• Khatib R, McKee M, Shannon H, Chow C, Rangarajan S, Teo K, et al. Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data. Lancet. 2016;387(10013):61–69.
   PubMed Web of Science ®Google Scholar
• Rida NA, Ibrahim MM, Babar Z. Relationship between pharmaceutical pricing strategies with price, availability, and affordability of cardiovascular disease medicines: surveys in Qatar and Lebanon. BMC Health Serv Res. 2019;19(1):1–14.
   PubMed Web of Science ®Google Scholar
• Abrha S, Tadesse E, Atey TM, Molla F, Melkam W, Masresha B, et al. Availability and affordability of priority life-saving medicines for under-five children in health facilities of Tigray region, northern Ethiopia. BMC Pregnancy Childbirth. 2018;18(1):1–9.
   PubMedGoogle Scholar
• Alefan Q, Amairi R, Tawalbeh S. Availability, prices and affordability of selected essential medicines in Jordan: a national survey. BMC Health Serv Res. 2018;18(1):1–12.
   PubMedGoogle Scholar
• Ahmad NS, Islahudin F. Affordability of essential medicine prices in Malaysia’s private health sector. Patient Prefer Adher. 2018;12:1231.
   PubMed Web of Science ®Google Scholar
• Ewen M, Zweekhorst M, Regeer B, Laing R. Baseline assessment of WHO’s target for both availability and affordability of essential medicines to treat non-communicable diseases. PLoS ONE. 2017;12(2): e0171284.
   PubMed Web of Science ®Google Scholar
• Ewen M, Kaplan W, Gedif T, Justin-Temu M, Vialle-Valentin C, Mirza Z, et al. Prices and availability of locally produced and imported medicines in Ethiopia and Tanzania. J Pharm Policy Pract. 2017;10(1):1–9.
   PubMedGoogle Scholar
• Mendis S, Fukino K, Cameron A, Laing R, Filipe A Jr, Khatib O, et al. The availability and affordability of selected essential medicines for chronic diseases in six low-and middle-income countries. Bull World Health Organ. 2007;85:279–288.
   PubMed Web of Science ®Google Scholar
• Nguyen TA, Knight R, Roughead EE, Brooks G, Mant A. Policy options for pharmaceutical pricing and purchasing: issues for low-and middle-income countries. Health Policy Plan. 2015;30(2):267–280.
   PubMed Web of Science ®Google Scholar
• Bizimana T, Kayumba PC, Heide L. Prices, availability and affordability of medicines in Rwanda. PLoS ONE. 2020;15(8): e0236411.
   PubMed Web of Science ®Google Scholar
• Khanal S, Veerman L, Ewen M, Nissen L, Hollingworth S. Availability, price, and affordability of essential medicines to manage noncommunicable diseases: a national survey from Nepal. INQUIRY J Health Care Organ Provis Financ. 2019;56: 0046958019887572.
   PubMed Web of Science ®Google Scholar
• Saeed A, Saeed H, Saleem Z, Fang Y, Babar Z-U-D. Evaluation of prices, availability and affordability of essential medicines in Lahore Division, Pakistan: a cross-sectional survey using WHO/HAI methodology. PLoS ONE. 2019;14(4): e0216122.
   PubMed Web of Science ®Google Scholar
• Sun X, Wei J, Yao Y, Chen Q, You D, Xu X, et al. Availability, prices and affordability of essential medicines for children: a cross-sectional survey in Jiangsu Province, China. BMJ Open. 2018;8(10): e023646.
   PubMed Web of Science ®Google Scholar
• Wang H, Sun Q, Vitry A, Nguyen TA. Availability, price, and affordability of selected essential medicines for chronic diseases in 11 countries of the Asia Pacific region: a secondary analysis. Asia Pac J Public Health. 2017;29(4):268–277.
   PubMed Web of Science ®Google Scholar
• Wong SL, Ibrahim S, Kadir NA, Salleh SM. Access and affordability of medicines in Malaysia: need for a national pricing policy. Appl Health Econ Health Policy. 2019;17(5):641–654.
   PubMed Web of Science ®Google Scholar
• Wu G, Gong S, Cai H, Ding Y. The availability, price and affordability of essential antibacterials in Hubei province, China. BMC Health Serv Res. 2018;18(1):1–8.
   PubMedGoogle Scholar
• Xi X, Li W, Li J, Zhu X, Fu C, Wei X, et al. A survey of the availability, prices and affordability of essential medicines in Jiangsu Province China. BMC Health Serv Res. 2015;15(1):1–7.
   PubMedGoogle Scholar
• Xu R, Li S, Lv X, Xie X. Prices, availability, and affordability of national essential medicines in public primary hospitals: a cross-sectional survey in poverty-stricken rural areas in China. Int J Health Plan Manag. 2020;35(2):545–557.
   PubMed Web of Science ®Google Scholar
• Attaei MW, Khatib R, McKee M, Lear S, Dagenais G, Igumbor EU, et al. Availability and affordability of blood pressure-lowering medicines and the effect on blood pressure control in high-income, middle-income, and low-income countries: an analysis of the PURE study data. Lancet Public Health. 2017;2(9):e411–e419.
   PubMed Web of Science ®Google Scholar
• Chow CK, Ramasundarahettige C, Hu W, AlHabib KF, Avezum A Jr, Cheng X, et al. Availability and affordability of essential medicines for diabetes across high-income, middle-income, and low-income countries: a prospective epidemiological study. Lancet Diabetes Endocrinol. 2018;6(10):798–808.
   PubMed Web of Science ®Google Scholar
• Babar Z-U-D, Ramzan S, El-Dahiyat F, Tachmazidis I, Adebisi A, Hasan SS. The availability, pricing, and affordability of essential diabetes medicines in 17 low-, middle-, and high-income countries. Front Pharmacol. 2019;10:1375.
   PubMed Web of Science ®Google Scholar
• Shrestha R, Ghale A, Chapagain BR, Gyawali M, Acharya T. Survey on the availability, price and affordability of selected essential medicines for non-communicable diseases in community pharmacies of Kathmandu valley. SAGE Open Med. 2017;5:2050312117738691.
   Google Scholar
• Kaiser AH, Hehman L, Forsberg BC, Simangolwa WM, Sundewall J. Availability, prices and affordability of essential medicines for treatment of diabetes and hypertension in private pharmacies in Zambia. PLoS ONE. 2019;14(12): e0226169.
   PubMed Web of Science ®Google Scholar
• Kasonde L, Tordrup D, Naheed A, Zeng W, Ahmed S. Evaluating medicine prices, availability and affordability in Bangladesh using World Health Organisation and Health Action International methodology. BMC Health Serv Res. 2019;19(1):1–12.
   PubMedGoogle Scholar
• Khuluza F, Haefele-Abah C. The availability, prices and affordability of essential medicines in Malawi: a cross-sectional study. PLoS ONE. 2019;14(2): e0212125.
   PubMed Web of Science ®Google Scholar
• Gelders S, Ewen M, Noguchi N, Laing R. Price, availability and affordability. An international comparison of chronic disease medicines Cairo: World Health Organization Regional Office for the Eastern Mediterranean 2006.
   Google Scholar
• Su M, Zhang Q, Bai X, Wu C, Li Y, Mossialos E, et al. Availability, cost, and prescription patterns of antihypertensive medications in primary health care in China: a nationwide cross-sectional survey. Lancet. 2017;390(10112):2559–2568.
   PubMed Web of Science ®Google Scholar
• Perehudoff SK, Alexandrov NV, Hogerzeil HV. Access to essential medicines in 195 countries: a human rights approach to sustainable development. Glob Public Health. 2019;14(3):431–444.
   PubMed Web of Science ®Google Scholar
• Klein EY, Milkowska-Shibata M, Tseng KK, Sharland M, Gandra S, Pulcini C, et al. Assessment of WHO antibiotic consumption and access targets in 76 countries, 2000–15: an analysis of pharmaceutical sales data. Lancet Infect Dis. 2021;21(1):107–115.
   PubMed Web of Science ®Google Scholar
• Moye-Holz D, van Dijk JP, Reijneveld SA, Hogerzeil HV. Policy approaches to improve availability and affordability of medicines in Mexico—an example of a middle income country. Glob Health. 2017;13(1):1–10.
   PubMedGoogle Scholar